Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DERM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
15 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 7
71 filers reported a long position in DERM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| WASATCH ADVISORS LP | $20.2M | 2.9M | +34% |
| TANG CAPITAL MANAGEMENT LLC | $11.4M | 1.6M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.8M | 675.2K | -37.6% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $3.8M | 536K | New |
| Pale Fire Capital SE | $3.7M | 528.6K | +9.7% |
| Opaleye Management Inc. | $2.5M | 350K | -63.5% |
| Summit Financial, LLC | $2.5M | 346.7K | -8.7% |
| JANE STREET GROUP, LLC | $2.3M | 320K | New |
| Diametric Capital, LP | $2.1M | 295.7K | +50.5% |
| Ikarian Capital, LLC | $1.8M | 251.4K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.